ALB and hepatocellular carcinoma: Studies conducted by Shen et al. [123] and Liu et al. [124] revealed that a low pre-treatment serum ALB/gamma-glutamyltransferase (GGT) ratio was independently correlated with worse OS and RFS in HCC patients receiving curative surgical resection or RFA.